XNCR

Xencor (XNCR)

Xencor Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XNCR

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XNCR	Xencor Inc
2024/05/10	05 : 09	Business Wire	Xencor Reports First Quarter 2024 Financial Results	NASDAQ:XNCR	Xencor Inc
2024/05/10	05 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:XNCR	Xencor Inc
2024/04/09	21 : 01	Business Wire	Xencor Appoints Bart Cornelissen as Chief Financial Officer	NASDAQ:XNCR	Xencor Inc
2024/03/12	04 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/12	04 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/12	04 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/12	04 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/08	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/03/07	04 : 39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/06	22 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XNCR	Xencor Inc
2024/03/06	06 : 48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/06	06 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/03/06	06 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/02/29	06 : 01	Business Wire	Xencor to Present at Upcoming Investor Conferences	NASDAQ:XNCR	Xencor Inc
2024/02/28	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:XNCR	Xencor Inc
2024/02/28	06 : 01	Business Wire	Xencor Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:XNCR	Xencor Inc
2024/02/21	06 : 31	Business Wire	Xencor to Host Webcast to Review Fourth Quarter and Full Year 2023 Financial Results and Provide Vudalimab Clinical Update	NASDAQ:XNCR	Xencor Inc
2024/02/17	07 : 43	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XNCR	Xencor Inc
2024/02/17	06 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/02/15	08 : 54	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XNCR	Xencor Inc
2024/02/15	04 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:XNCR	Xencor Inc
2024/02/14	06 : 07	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:XNCR	Xencor Inc
2024/01/20	04 : 40	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:XNCR	Xencor Inc
2024/01/04	06 : 01	Business Wire	Xencor to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:XNCR	Xencor Inc